VA Arlington의 비소세포폐암 임상 시험
비소세포폐암 관련 연구 104개가 Arlington 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
피험자 모집 중3상
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5마일 거리
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
피험자 모집 중3상
- Virginia Cancer Specialists ( Site 0167), Fairfax · 11마일 거리
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
피험자 모집 중1/2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
피험자 모집 중2/3상
- Virginia Cancer Specialists, PC, Fairfax · 11마일 거리
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- Inova Schar Cancer Institute, Fairfax · 11마일 거리
- NEXT Virginia, Fairfax · 11마일 거리
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
피험자 모집 중3상
- Virginia Cancer Specialists ( Site 0114), Fairfax · 11마일 거리
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
피험자 모집 중1상
- ALX Center 2, Fairfax · 11마일 거리
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
피험자 모집 중1상
- Site 04, Fairfax · 11마일 거리
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
피험자 모집 중2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
피험자 모집 중3상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
피험자 모집 중3상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
A Study of PHN-012 in Patients With Advanced Solid Tumors
피험자 모집 중1상
- PHN-012-001 Site, Fairfax · 11마일 거리
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
피험자 모집 중2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
피험자 모집 중1/2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
피험자 모집 중2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
피험자 모집 중1상
- Virginia Cancer Specialists PC, Fairfax · 11마일 거리
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
피험자 모집 중2상
- Research Site, Fairfax · 11마일 거리
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
피험자 모집 중2/3상
- Virginia Cancer Specialists - Arlington, Arlington
- Virginia Cancer Specialists, Fairfax · 11마일 거리
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
피험자 모집 중1/2상
- NEXT Oncology Virginia, Fairfax · 11마일 거리
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
피험자 모집 중2상
- Virginia Cancer Specialists - Fairfax /ID# 272004, Fairfax · 11마일 거리
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
피험자 모집 중1/2상
- Inova Schar Cancer Institute Clinical Trials, Fairfax · 11마일 거리
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
피험자 모집 중1상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
피험자 모집 중1/2상
- Next Oncology Virginia Cancer Specialist, Fairfax · 11마일 거리
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
피험자 모집 중3상
- Research Site, Fairfax · 11마일 거리
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
피험자 모집 중3상
- Clinical Study Site, Fairfax · 11마일 거리
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
피험자 모집 중3상
- Virginia Cancer Specialists, Arlington
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
피험자 모집 중1상
- NEXT - Virginia, Fairfax · 11마일 거리
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
피험자 모집 중3상
- Virginia Cancer Specialists, PC, Fairfax · 11마일 거리
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
피험자 모집 중1/2상
- NEXT Virginia, Fairfax · 11마일 거리
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
피험자 모집 중2/3상
- Local Institution - 007-814-D, Arlington
- USOR - Virginia Cancer Specialists - Fairfax Office, Fairfax · 11마일 거리
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
피험자 모집 중1/2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
피험자 모집 중1/2상
- Inova Schar Cancer Institute, Fairfax · 11마일 거리
- Next Oncology Virginia, Fairfax · 11마일 거리
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
피험자 모집 중2상
- Virginia Cancer Specialists (Fairfax) - USOR, Fairfax · 11마일 거리
A Phase 1/1b Study of IAM1363 in HER2 Cancers
피험자 모집 중1상
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11마일 거리
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
피험자 모집 중3상
- USO - Virginia Cancer Specialists, Fairfax · 11마일 거리
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- USO-Virginia Cancer Specialists, PC, Fairfax · 11마일 거리
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
피험자 모집 중1상
- NEXT Oncology Virginia, Fairfax · 11마일 거리
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
피험자 모집 중3상
- Research Site, Fairfax · 11마일 거리
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
피험자 모집 중1상
- NEXT Oncology, Fairfax · 11마일 거리
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
피험자 모집 중1/2상
- NEXT Virginia, Fairfax · 11마일 거리
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
피험자 모집 중1/2상
- NEXT Virginia, Fairfax · 11마일 거리
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
피험자 모집 중1상
- Virginia Cancer Specialists, PC, Fairfax · 11마일 거리
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
피험자 모집 중1상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- NEXT Virginia, Fairfax · 11마일 거리
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
피험자 모집 중3상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
피험자 모집 중2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
피험자 모집 중3상
- Research Site, Fairfax · 11마일 거리
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
피험자 모집 중1/2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
피험자 모집 중1상
- Inova Schar Cancer Institute, Falls Church · 4마일 거리
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- Research Site, Fairfax · 11마일 거리
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
피험자 모집 중3상
- Inova Schar Cancer Institute, Fairfax · 11마일 거리
- Inova Fair Oaks Hospital, Fairfax · 11마일 거리
A Study of DM005 in Patients With Advanced Solid Tumors
피험자 모집 중1/2상
- NEXT Oncology Virginia, Fairfax · 11마일 거리
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- Clinical Trial Site, Fairfax · 11마일 거리
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
피험자 모집 중1/2상
- NEXT Virginia, Fairfax · 11마일 거리
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
피험자 모집 중1/2상
- NEXT Virginia, Fairfax · 11마일 거리
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
피험자 모집 중1상
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11마일 거리
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
피험자 모집 중1/2상
- USOR Virginia Cancer Specialists, Fairfax · 11마일 거리
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
피험자 모집 중1/2상
- NEXT Virginia, Fairfax · 11마일 거리
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- Next Virginia, Fairfax · 11마일 거리
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
피험자 모집 중3상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
피험자 모집 중1상
- NEXT Virginia, Fairfax · 11마일 거리
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
피험자 모집 중1상
- NEXT Virginia, Fairfax · 11마일 거리
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
피험자 모집 중1/2상
- NEXT Virginia, Fairfax · 11마일 거리
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
피험자 모집 중1상
- NEXT Virginia, Fairfax · 11마일 거리
A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer
피험자 모집 중1/2상
- Research Site, Fairfax · 11마일 거리
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
피험자 모집 중1상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
피험자 모집 중1상
- NEXT Virginia, Fairfax · 11마일 거리
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
피험자 모집 중2상
- Research Site, Fairfax · 11마일 거리
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
피험자 모집 중1/2상
- NEXT Oncology Virginia, Fairfax · 11마일 거리
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
피험자 모집 중1상
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · 11마일 거리
A Study of LY4175408 in Participants With Advanced Cancer
피험자 모집 중1상
- NEXT Virginia, Fairfax · 11마일 거리
Study of XB010 in Subjects With Solid Tumors
피험자 모집 중1상
- Inova Schar Cancer, Fairfax · 11마일 거리
- NEXT Virginia, Fairfax · 11마일 거리
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
피험자 모집 중1상
- NEXT Texas LLC - Virginia, Fairfax · 11마일 거리
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
피험자 모집 중1상
- NEXT Virginia, Fairfax · 11마일 거리
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- Research Site, Fairfax · 11마일 거리
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
피험자 모집 중1상
- Research Site, Fairfax · 11마일 거리
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
피험자 모집 중2상
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5마일 거리
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
피험자 모집 중1상
- NEXT Oncology Virginia, Fairfax · 11마일 거리
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
피험자 모집 중1/2상
- NEXT Virginia, Fairfax · 11마일 거리
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
피험자 모집 중1/2상
- NEXT Oncology, Fairfax · 11마일 거리
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
피험자 모집 중3상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
피험자 모집 중1상
- NEXT Oncology Virginia, Fairfax · 11마일 거리
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
피험자 모집 중1/2상
- Next Oncology Virginia, Fairfax · 11마일 거리
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
피험자 모집 중3상
- Research Site, Fairfax · 11마일 거리
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
피험자 모집 중2상
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5마일 거리
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
피험자 모집 중2/3상
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5마일 거리
A 2-part Phase 1/2 Open-label Trial on ODM-212
피험자 모집 중1/2상
- NEXT Oncology Virginia, Fairfax · 11마일 거리
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
피험자 모집 중2상
- Inova Fairfax Hospital, Fairfax · 11마일 거리
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
피험자 모집 중1/2상
- NEXT Virginia, Fairfax · 11마일 거리
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
피험자 모집 중1/2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
피험자 모집 중1상
- Research Site, Fairfax · 11마일 거리
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
피험자 모집 중1/2상
- NEXT Virginia, Fairfax · 11마일 거리
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
피험자 모집 중1/2상
- NEXT Virginia, Fairfax · 11마일 거리
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- NEXT Virginia, Fairfax · 11마일 거리
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
피험자 모집 중1/2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- NEXT Virginia, Fairfax · 11마일 거리
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
피험자 모집 중1/2상
- NEXT, Virginia, Fairfax · 11마일 거리
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
피험자 모집 중1상
- Dren Investigational Site, Fairfax · 11마일 거리
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
피험자 모집 중1상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
피험자 모집 중1상
- NEXT Oncology, Fairfax · 11마일 거리
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
피험자 모집 중1/2상
- Research Site 102, Fairfax · 11마일 거리
- Research Site 112, Fairfax · 11마일 거리
A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer
피험자 모집 중2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
피험자 모집 중1/2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
피험자 모집 중1/2상
- NEXT Virginia, Fairfax · 11마일 거리
다른 도시의 비소세포폐암 시험
- Houston, TX연구 145개
- New York City, NY연구 120개
- Nashville, TN연구 97개
- Boston, MA연구 90개
- Los Angeles, CA연구 87개
- St. Louis, MO연구 73개
- Chicago, IL연구 61개
- Baltimore, MD연구 60개
- San Antonio, TX연구 59개
- Columbus, OH연구 56개
- Washington, DC연구 55개
- Seattle, WA연구 53개
Arlington의 다른 연구
- 전이성 암연구 53개
- 대장직장암연구 52개
- 암 (전체)연구 48개
- 유방암연구 46개
- 난소암연구 46개
- 폐암연구 41개
- 자궁내막암연구 39개
- 췌장암연구 33개
- 두경부 편평세포암연구 26개
- 소세포 폐암연구 23개
- 삼중음성 유방암연구 20개
- 위암연구 20개
ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.